Occupational risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare personnel: A cross-sectional analysis of subjects enrolled in the COVID-19 Prevention in Emory Healthcare Personnel (COPE) study.


Journal

Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099

Informations de publication

Date de publication:
03 2022
Historique:
pubmed: 10 2 2021
medline: 1 4 2022
entrez: 9 2 2021
Statut: ppublish

Résumé

Among 353 healthcare personnel in a longitudinal cohort in 4 hospitals in Atlanta, Georgia (May-June 2020), 23 (6.5%) had severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies. Spending >50% of a typical shift at the bedside (OR, 3.4; 95% CI, 1.2-10.5) and black race (OR, 8.4; 95% CI, 2.7-27.4) were associated with SARS-CoV-2 seropositivity.

Identifiants

pubmed: 33557990
pii: S0899823X21000544
doi: 10.1017/ice.2021.54
pmc: PMC8160492
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

381-386

Subventions

Organisme : NIAID NIH HHS
ID : T32 AI074492
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI104681
Pays : United States

Auteurs

Jessica R Howard-Anderson (JR)

Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
Georgia Emerging Infections Program, Atlanta, Georgia.

Carly Adams (C)

Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia.

Amy C Sherman (AC)

Hope Clinic of the Emory Vaccine Center, Atlanta, Georgia.
Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts.

William C Dube (WC)

Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.

Teresa C Smith (TC)

Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia.

Neena Edupuganti (N)

Hope Clinic of the Emory Vaccine Center, Atlanta, Georgia.

Nora Chea (N)

Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

Shelley S Magill (SS)

Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

Daniel O Espinoza (DO)

Hope Clinic of the Emory Vaccine Center, Atlanta, Georgia.

Yerun Zhu (Y)

Hope Clinic of the Emory Vaccine Center, Atlanta, Georgia.

Varun K Phadke (VK)

Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
Hope Clinic of the Emory Vaccine Center, Atlanta, Georgia.

Srilatha Edupuganti (S)

Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
Hope Clinic of the Emory Vaccine Center, Atlanta, Georgia.

James P Steinberg (JP)

Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.

Benjamin A Lopman (BA)

Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia.

Jesse T Jacob (JT)

Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
Georgia Emerging Infections Program, Atlanta, Georgia.
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia.

Matthew H Collins (MH)

Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
Hope Clinic of the Emory Vaccine Center, Atlanta, Georgia.

Scott K Fridkin (SK)

Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
Georgia Emerging Infections Program, Atlanta, Georgia.
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH